12 Results for "

SRC-3

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "SRC-3" in MCE Product Catalog:

Cat. No.: HY-101447A
CAS No.: 1992052-49-9
Purity:  99.79%
Synonyms: EPH 116 hydrochloride
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

SI-2 (EPH 116 hydrochloride) is a highly promising SRC-3 inhibitor (PPI). SI-2 (EPH 116 hydrochloride) has a much improved toxicity and pharmacokinetic profile, with acceptable oral availability .
loading...
    loading...
Cat. No.: HY-163469
CAS No.: 3074959-44-4
Target:  

Src

Research Areas:  

Cancer

SRC-3-IN-2 (SI-12 6c)is an orally active steroid receptor coactivator 3 (SRC-3) inhibitor. SRC-3-IN-2 has antitumor activity .
loading...
    loading...
Cat. No.: HY-RS09091
Research Areas:  

Others

NCOA3 Human Pre-designed siRNA Set A contains three designed siRNAs for NCOA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-163468
CAS No.: 2137490-93-6
Target:  

Src

Research Areas:  

Cancer

SRC-3-IN-1 (compound SI-10) is a steroid receptor coactivator 3 (SRC-3) inhibitor (IC50=3.3 μM). SRC-3-IN-1 has good water solubility, oral bioavailability, and improved selectivity profile. SRC-3-IN-1 can be used in prostate cancer research .
loading...
    loading...
Cat. No.: HY-101447
CAS No.: 223788-33-8
Synonyms: EPH 116
Target:  

Src Apoptosis

Research Areas:  

Cancer

SI-2 (EPH 116) is an inhibitor for steroid receptor coactivator-3 (SRC-3), which reduces the transcriptional activity and protein concentration of SRC-3 in cells, exhibits cytotoxicity in cancer cell, inhibits migration of MDA-MB-468, induces apoptosis of MDA-MB-468. SI-2 inhibits the tumor growth in mouse models, without significant toxicity for heart and other major organs (20 mg/kg) .
loading...
    loading...
Cat. No.: HY-176225
CAS No.: 3117131-00-4
Research Areas:  

Cancer

BY13 is a SRC-3 PROTAC degrader with a DC50 of 0.031 μM. BY13 selectively blocks the ER signaling pathway over that of androgen receptor (AR)) through down-regulating ERα level. BY13 potently overcomes endocrine resistance in breast cancer by inducing cell cycle arrest in G1 phase and apoptosis, with superior effect over Fulvestrant (HY-13636). BY13 significantly inhibits the growth of drug-resistant breast tumors without obvious toxicity in LCC2 xenograft mice model .
loading...
    loading...
Cat. No.: HY-121582
CAS No.: 380537-35-9
Synonyms: (E)-EPH 116
Target:  

Drug Isomer

Research Areas:  

Cancer

(E)-SI-2 is an isomer of SI-2, an inhibitor of the steroid receptor coactivator SRC-3. SI-2 has anticancer activity and increases the number of cytotoxic immune cells in mice with breast cancer .
loading...
    loading...
Cat. No.: HY-RS20451
Research Areas:  

Others

Ncoa3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ncoa3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-N14903
CAS No.: 664365-72-4
Oximidine III is an anti-tumor antibiotic. Oximidine III can selectively inhibit the growth of 3Y1 in rat fibroblasts with degeneration of various tumor genes. Oximidine III inhibits v-H-ras-3Y1, v-src-3Y1 cells and the normal 3Y1 cells with IC50s (nM) of 14, 4.5 and 140, respectively. Oximidine III stops RAS-or SRC-denatured cells at G1 phase of the cell cycle and increases p21WAF1 expression .
loading...
    loading...
Cat. No.: HY-101447AR
CAS No.: 1992052-49-9
Synonyms: EPH 116 hydrochloride (Standard)
Research Areas:  

Cancer

SI-2 (hydrochloride) (Standard) is the analytical standard of SI-2 (hydrochloride) (HY-101447A). This product is intended for research and analytical applications. SI-2 (EPH 116 hydrochloride) is a highly promising SRC-3 inhibitor (PPI). SI-2 (EPH 116 hydrochloride) has a much improved toxicity and pharmacokinetic profile, with acceptable oral availability .
loading...
    loading...
Cat. No.: HY-180398
CAS No.: 95520-87-9
Target:  

PPAR PGC-1α

Research Areas:  

Metabolic Disease

PA-082 is a selective PPAR-γ modulator that functions as a partial agonist. PA-082 causes partial recruitment of SRC1, TIF2, SRC3 and full recruitment of PGC1-α to PPAR-γ ligand-binding domain. PA-082 prevents triglyceride accumulation during de novo adipogenesis and antagonizes Rosiglitazone (HY-17386)-induced lipid accumulation. PA-082 potentiates insulin-stimulated glucose uptake in adipocytes and protects against TNFα-induced insulin resistance. PA-082 can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-181427
CAS No.: 2698320-33-9
Target:  

Androgen Receptor

Research Areas:  

Cancer

UT-143 is an orally active, selective irreversible covalent antagonist of androgen receptor (AR). UT-143 inhibits the proliferation of AR-positive prostate cancer cells, reduces the weight of androgen target tissues in rats, and suppresses the growth of AR-positive xenograft tumors. UT-143 can be used for the research of prostate cancer .
loading...
    loading...
  • 1